<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"> 
  <channel> 
    <title>Amedisys, Inc</title> 
    <link/> 
    <description>Press Releases</description> 
    <language>en-us</language> 
    <ttl>40</ttl> 
   
   
	
	
		
    <item> 
   <title><![CDATA[Amedisys to Present at the Raymond James and Associates 31st Annual Institutional Investors Conference]]></title>
     <description><![CDATA[BATON ROUGE, Louisiana (March 5, 2010) - Amedisys, Inc. (NASDAQ: "AMED"), one of America's leading home care and hospice companies, today announced that Dale E. Redman, Chief Financial Officer, will present at the Raymond James and Associates 31st Annual Institutional Investors Conference in Orlando, FL on Wednesday, March 10, 2010.    <P>
The presentation will begin at 10:25 a.m. Eastern time.  A live webcast of the presentation can be accessed through a link on our Investor Relations page at the following web address:     <P>
<a href="http://www.amedisys.com/investors" target="_blank">http://www.amedisys.com/investors</a>    <P>
Amedisys, Inc. is headquartered in Baton Rouge, Louisiana.  Our common stock trades on the Nasdaq Global Select Market under the symbol "AMED".    <P>
<em>Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page.  We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information.  In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").</em> <P>]]></description>
      <pubDate>2010-03-05 00:00:00.0</pubDate> 
      <link>http://www.amedisys.com/press_release.cfm?ID=223</link> 
      <creator>Amedisys.com</creator> 
    </item> 
		

	
		
    <item> 
   <title><![CDATA[Amedisys to Present at the RBC Capital Markets 2010 Healthcare Conference]]></title>
     <description><![CDATA[BATON ROUGE, Louisiana (February 25, 2010) - Amedisys, Inc. (NASDAQ: "AMED"), one of America's leading home care and hospice companies, today announced that William F. Borne, Chief Executive Officer will participate in the home health panel discussion at the RBC Capital Markets 2010 Healthcare Conference in New York City at 11:00 am ET on Wednesday, March 3, 2010.    <P>
The panel discussion will be webcast live and can be accessed through a link on our Investor Relations page at the following web address:     <P>
<a href="http://www.amedisys.com/investors" target="_blank">http://www.amedisys.com/investors</a>    <P>
Amedisys, Inc. is headquartered in Baton Rouge, Louisiana.  Our common stock trades on the Nasdaq Global Select Market under the symbol "AMED".    <P>
<em>Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page.  We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information.  In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").</em> <P>]]></description>
      <pubDate>2010-02-25 00:00:00.0</pubDate> 
      <link>http://www.amedisys.com/press_release.cfm?ID=222</link> 
      <creator>Amedisys.com</creator> 
    </item> 
		

	
		
    <item> 
   <title><![CDATA[Amedisys Reports Fourth Quarter Revenue and Earnings and Issues 2010 Guidance]]></title>
     <description><![CDATA[AMEDISYS TO HOST CONFERENCE CALL TODAY AT 10:00 A.M. ET    <P>
BATON ROUGE, Louisiana (February 23, 2010) — Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health nursing companies, today reported its financial results for the three months and year ended December 31, 2009. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 19.2% and 43.5%, respectively, over the three month period ended December 31, 2008.    <P>
To view the entire document, visit <a href="http://www.amedisys.com/pdf/022310_AMED_Q4_Earnings.pdf" target="_blank">http://www.amedisys.com/pdf/022310_AMED_Q4_Earnings.pdf</a> <P>]]></description>
      <pubDate>2010-02-23 00:00:00.0</pubDate> 
      <link>http://www.amedisys.com/press_release.cfm?ID=220</link> 
      <creator>Amedisys.com</creator> 
    </item> 
		

	
		
    <item> 
   <title><![CDATA[Amedisys Sets Earnings Date and Investor Conference Call]]></title>
     <description><![CDATA[BATON ROUGE, Louisiana (February 3, 2010) - Amedisys, Inc. (NASDAQ: "AMED"), one of America's leading home health and hospice nursing companies, today announced that it will host a conference call with the investment community on Tuesday, February 23, 2010 at 10:00 a.m. ET to discuss its financial and business performance.  The Company intends to release its financial results for the fourth quarter and year ended December 31, 2009 pre-market on Tuesday, February 23, 2010.      <P>
To participate in the conference call, please dial 888-204-4520 (Toll free) or 913-312-0937 (Toll) a few minutes before 10:00 a.m. ET on Tuesday, February 23, 2010.  A replay of the conference call will be available through March 2, 2010.  The replay dial in number is 888-203-1112 (Toll free) or 719-457-0820 (Toll). The replay pin number is 6461385.     <P>
The call will also be available though our website and for seven days thereafter on our Investor Relations page at the following web address:    <P>
<a href="http://www.amedisys.com/investors" target="_blank">http://www.amedisys.com/investors</a>    <P>
Amedisys, Inc. (the "Company") is headquartered in Baton Rouge, Louisiana.  Our common stock trades on the NASDAQ Global Select Market under the symbol "AMED".    <P>
<em>Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page.  We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information.  In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").</em> <P>]]></description>
      <pubDate>2010-02-03 00:00:00.0</pubDate> 
      <link>http://www.amedisys.com/press_release.cfm?ID=219</link> 
      <creator>Amedisys.com</creator> 
    </item> 
		

	
		
    <item> 
   <title><![CDATA[Amedisys Acquires Arkansas Home Health Agency]]></title>
     <description><![CDATA[BATON ROUGE, Louisiana (February 2, 2010) - Amedisys, Inc. (NASDAQ: "AMED"), one of America's leading home health and hospice companies, today announced that it has acquired De Queen Home Health Agency located in De Queen, Arkansas, a Permit of Approval state.   The acquisition will expand Amedisys' coverage to all or part of eight new counties, bringing our total coverage of Arkansas to 32 counties.  De Queen had annualized revenue of $2.9 million, but is not expected to add materially to Amedisys earnings in 2010.    <P>
"We welcome the new employees from De Queen into the Amedisys family and look forward to expanding our presence in Arkansas," stated William F. Borne, Chief Executive Officer of Amedisys, Inc.  "De Queen has a long history and great reputation of providing quality service to the communities they serve.  We are very excited to be able to build upon that reputation by introducing our technologies and expanding services with our disease management programs."    <P>
Amedisys, Inc. is headquartered in Baton Rouge, Louisiana.  Its common stock trades on the NASDAQ Global Select Market under the symbol "AMED".    <P>
<em>This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect", "anticipate" or similar expressions.  Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements.  Many of the factors that could cause or contribute to such differences are described in the Company's periodic reports and registrations statements filed with the Securities and Exchange Commission, and include, but are not limited to the following: general economic and business conditions, changes in or failure to comply with existing regulations or the inability to comply with new government regulations on a timely basis, changes in Medicare and other medical reimbursement levels, ability to complete acquisitions announced from time to time, and any financing related thereto, the ability to meet debt service requirements and to comply with covenants in debt agreements, adverse changes in federal and state laws relating to the health care industry, demographic changes, availability and terms of capital, ability to attract and retain qualified personnel, ongoing development and success of new start-ups, ability to successfully integrate newly acquired agencies, changes in estimates and judgments associated with critical accounting policies, business disruption due to natural disasters or acts of terrorism, and various other matters, many of which are beyond management's control. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. </em>    <P>
<em>Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page.  We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information.  In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").</em>    <P>
  Additional information on the Company can be found at:  <a href="http://www.amedisys.com" target="_blank">www.amedisys.com</a> <P>]]></description>
      <pubDate>2010-02-02 00:00:00.0</pubDate> 
      <link>http://www.amedisys.com/press_release.cfm?ID=218</link> 
      <creator>Amedisys.com</creator> 
    </item> 
		

	
		
    <item> 
   <title><![CDATA[Amedisys to Present at the Jefferies 2010 Global Healthcare Services Conference]]></title>
     <description><![CDATA[BATON ROUGE, Louisiana (January 22, 2010) - Amedisys, Inc. (NASDAQ: "AMED", one of America's leading home care and hospice companies, today announced that William F. Borne, Chief Executive Officer, and Dale E. Redman, Chief Financial Officer, will present at the Jefferies 2010 Global Healthcare Services Conference in New York, NY on Tuesday, January 26, 2010.     <P>
The presentation will begin at 11:45 a.m. Eastern time.  The audio presentation will be webcast live and can be accessed through a link on our Investor Relations page at the following web address:     <P>
<a href="http://www.amedisys.com/investors" target="_blank">http://www.amedisys.com/investors</a>    <P>
Amedisys, Inc. is headquartered in Baton Rouge, Louisiana.  Our common stock trades on the Nasdaq Global Select Market under the symbol "AMED".    <P>
<em>Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page.  We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information.  In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").</em>   <P>]]></description>
      <pubDate>2010-01-22 00:00:00.0</pubDate> 
      <link>http://www.amedisys.com/press_release.cfm?ID=217</link> 
      <creator>Amedisys.com</creator> 
    </item> 
		

	
		
    <item> 
   <title><![CDATA[Amedisys Signs Agreement with Humana to Provide Home Health Services]]></title>
     <description><![CDATA[BATON ROUGE, Louisiana (Jan. 20, 2010) — Amedisys Inc. (NASDAQ: AMED), one of America's leading home health nursing companies, today announced that it has signed a national agreement with Humana Inc. (NYSE: HUM) to provide home health services to Humana's Medicare Advantage members effective Jan. 1, 2010. The agreement covers approximately 1.5 million participants who are covered under various Humana Medicare Advantage plans in all 50 states.    <P>
"This agreement marks a substantial expansion of our relationship with Humana, as our previous agreement had been limited to just a few markets," said William F. Borne, chief executive officer of Amedisys Inc. "It also represents a significant milestone for Amedisys as it helps diversify our revenue base beyond direct Medicare payments, and shows the importance of our expanded geographical footprint, which allows us to better support national insurance providers. We will continue to explore similar opportunities to expand our services with other national insurance providers."    <P>
William A. Barnes, vice president of national contracting at Humana, added, "We are pleased to reach this agreement with Amedisys. It will be a great benefit to our Medicare Advantage members, providing them with better access to home health care services, which we believe will lead to better outcomes and fewer unnecessary hospital trips."    <P>
Humana Inc., headquartered in Louisville, Ky., is one of the nation's largest health and supplemental benefits companies.    <P>
Amedisys Inc. is headquartered in Baton Rouge, La. Its common stock trades on the NASDAQ Global Select Market under the symbol AMED.    <P>
<em>This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect", "anticipate" or similar expressions.  Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements.  Many of the factors that could cause or contribute to such differences are described in the Company's periodic reports and registrations statements filed with the Securities and Exchange Commission, and include, but are not limited to the following: general economic and business conditions, changes in or failure to comply with existing regulations or the inability to comply with new government regulations on a timely basis, changes in Medicare and other medical reimbursement levels, ability to complete acquisitions announced from time to time, and any financing related thereto, the ability to meet debt service requirements and to comply with covenants in debt agreements, adverse changes in federal and state laws relating to the health care industry, demographic changes, availability and terms of capital, ability to attract and retain qualified personnel, ongoing development and success of new start-ups, ability to successfully integrate newly acquired agencies, changes in estimates and judgments associated with critical accounting policies, business disruption due to natural disasters or acts of terrorism, and various other matters, many of which are beyond management's control. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. </em>    <P>
<em>Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page.  We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information.  In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").</em>    <P>
  Additional information on the Company can be found at:  <a href="http://www.amedisys.com" target="_blank">www.amedisys.com</a>   <P>]]></description>
      <pubDate>2010-01-20 00:00:00.0</pubDate> 
      <link>http://www.amedisys.com/press_release.cfm?ID=215</link> 
      <creator>Amedisys.com</creator> 
    </item> 
		

	
		
    <item> 
   <title><![CDATA[Amedisys Names Patrick Thompson as New Executive Vice President of Administration and Chief Information Officer]]></title>
     <description><![CDATA[BATON ROUGE, Louisiana (January 19, 2010) - Amedisys, Inc. (NASDAQ: "AMED") one of America's leading home care and hospice companies, announced today that G. Patrick Thompson, Jr., formerly Executive Vice President and Chief Administrative Officer of The Shaw Group, has joined Amedisys as the Company's new Executive Vice President of Administration and Chief Information Officer (CIO).     <P>
"Patrick is an experienced, effective leader and is going to be an excellent addition to our senior executive team," stated William F. Borne, Amedisys Chief Executive Officer.  "His expertise in IT and administration aligns completely with Amedisys' commitment to quality by improving efficiencies through technology and innovation."    <P>
Mr. Thompson has more than 23 years of experience in streamlining business processes and improving operational efficiencies, most recently as the Executive Vice President and Chief Administrative Officer of The Shaw Group, a Fortune 500 engineering, technology, construction, fabrication, nuclear, environmental and industrial services company with annual revenue of $7.3 billion in 2009, with approximately 28,000 employees throughout the world.  During his eight years with The Shaw Group, Mr. Thompson also held other positions, including Chief Information Officer and Executive Vice President and Chief Operating Officer for Shaw Environmental & Infrastructure, Inc. a subsidiary of Shaw.  Prior to The Shaw Group, Mr. Thompson served as Senior Vice President and Chief Information Officer with Turner Industries.  Before joining Turner Industries, Mr. Thompson was a senior manager for Andersen Consulting, now known as Accenture.  Mr. Thompson has a proven level of experience in implementing information systems in complex operating environments that delivers value to employees, clients, and business partners.  Among other honors and awards he was named to <em>Computerworld Magazine</em> Top 100 and featured in a <em>CIO Magazine</em> cover story.      <P>
In his role as Executive Vice President of Administration and CIO for Amedisys, Mr. Thompson is responsible for providing oversight and direction related to administrative functions.  Mr. Thompson will also be responsible for all Information Technology functions within the Company.  Mr. Thompson began his duties as Executive Vice President of Administration and CIO on January 18, 2010.     <P>
"I am very pleased to be joining the Amedisys team - a company with a proven track record and a promising future," said Mr. Thompson.  "Amedisys is positioned to capitalize on the dynamic challenges facing the healthcare industry and I look forward to working with my fellow employees to deliver on our vision of being the leader in chronic care management and driving shareholder value."    <P>
Amedisys, Inc. is headquartered in Baton Rouge, Louisiana.  Its common stock trades on the NASDAQ Global Select Market under the symbol "AMED."    <P>
<em>This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect", "anticipate" or similar expressions.  Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements.  Many of the factors that could cause or contribute to such differences are described in the Company's periodic reports and registrations statements filed with the Securities and Exchange Commission, and include, but are not limited to the following: general economic and business conditions, changes in or failure to comply with existing regulations or the inability to comply with new government regulations on a timely basis, changes in Medicare and other medical reimbursement levels, ability to complete acquisitions announced from time to time, and any financing related thereto, the ability to meet debt service requirements and to comply with covenants in debt agreements, adverse changes in federal and state laws relating to the health care industry, demographic changes, availability and terms of capital, ability to attract and retain qualified personnel, ongoing development and success of new start-ups, ability to successfully integrate newly acquired agencies, changes in estimates and judgments associated with critical accounting policies, business disruption due to natural disasters or acts of terrorism, and various other matters, many of which are beyond management's control. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. </em>    <P>
<em>Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page.  We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information.  In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").</em>    <P>
<a href="http://www.amedisys.com" target="_blank">www.amedisys.com</a>   <P>]]></description>
      <pubDate>2010-01-19 00:00:00.0</pubDate> 
      <link>http://www.amedisys.com/press_release.cfm?ID=214</link> 
      <creator>Amedisys.com</creator> 
    </item> 
		

	
		
    <item> 
   <title><![CDATA[Amedisys To Present At The 28th Annual J.P. Morgan Healthcare Conference]]></title>
     <description><![CDATA[BATON ROUGE, Louisiana (January 11, 2010) - Amedisys, Inc. (NASDAQ: "AMED", one of America's leading home care and hospice companies, today announced that William F. Borne, Chief Executive Officer, and Dale E. Redman, Chief Financial Officer, will present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Thursday, January 14, 2010.     <P>
The presentation will begin at 8:30 a.m. Pacific/11:30 a.m. Eastern time.  The audio presentation will be webcast live and can be accessed through a link on our Investor Relations page at the following web address:     <P>
<a href="http://www.amedisys.com/investors" target="_blank">http://www.amedisys.com/investors</a>    <P>
Amedisys, Inc. is headquartered in Baton Rouge, Louisiana.  Our common stock trades on the Nasdaq Global Select Market under the symbol "AMED".    <P>
<em>Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page.  We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information.  In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").</em> <P>]]></description>
      <pubDate>2010-01-11 00:00:00.0</pubDate> 
      <link>http://www.amedisys.com/press_release.cfm?ID=213</link> 
      <creator>Amedisys.com</creator> 
    </item> 
		

	
		
    <item> 
   <title><![CDATA[Amedisys Announces Two Additions to the Executive Leadership Team]]></title>
     <description><![CDATA[<em>Michael Snow and Tim Barfield to Join Amedisys in Key Leadership Positions</em>    <P>
BATON ROUGE, Louisiana (January 5, 2010) - Amedisys, Inc. (NASDAQ: "AMED") one of America's leading home care and hospice companies, announced today that Michael D. Snow, formerly President and CEO of Wellmont Health System, will join Amedisys as the Company's new Chief Operating Officer (COO); and Tim Barfield, formerly the Executive Counsel to Louisiana Governor Bobby Jindal, will join Amedisys as the Company's new Chief Development Officer.     <P>
"We are excited and honored to welcome both Mike Snow and Tim Barfield to the Amedisys family. Mike brings significant operational experience to our leadership team and understands the opportunities and challenges that lie ahead for Amedisys.  Tim's expertise in acquisitions, integration and growth will provide tremendous value to Amedisys as we move forward," stated William F. Borne, Amedisys Chief Executive Officer.  "Both Mike and Tim will report directly to me and I believe that their skill sets will complement each other and provide strong leadership for Amedisys."     <P>
Mr. Snow has more than 25 years of experience in healthcare business operations, most recently as President and CEO of Wellmont Health System, where he worked with the system's board of directors to update the organization's strategic plan. He also partnered with executives and physicians at the system's eight hospitals to standardize operations and maximize efficiencies to gain synergies from Wellmont's rapid growth in recent years.  Throughout Mr. Snow's career, he has improved operating performance, recruited and developed key staff, and strengthened relationships both internally and externally.      In 2007, Mr. Snow was appointed President and CEO of Surgical Care Affiliates, a spin-off from HealthSouth, and one of the largest providers of ambulatory surgery centers in the country with 132 sites in 33 states.  In 2008, he stepped down as the company's CEO in a planned departure and moved into a board role with the organization.  From 2004 to 2007 Mr. Snow was chief operating officer of HealthSouth Corp., the nation's largest provider of rehabilitative healthcare services.      <P>
Mr. Snow also worked for HCA, Inc. from 1995 until 2004, in his last position serving as president of HCA's Gulf Coast Division, one of the largest operating divisions of HCA with annual revenues in excess of $2 billion and more than 12,000 employees.    <P>
In his role as COO of Amedisys, Mr. Snow will be responsible for the Company's overall performance.  He will be in charge of the company's day-to-day operating activities, including delivering high quality healthcare; revenue growth; expense and margin control; as well as financial goal management.  Mr. Snow will join Amedisys full time as COO on March 1, 2010.       <P>
"I'm very pleased to be joining Amedisys – a company with a proud history and great promise," said Mr. Snow.  "This is a dynamic time in healthcare, and I look forward to working with the leadership and staff at Amedisys.  Bringing my own knowledge and experience to bear, I'm confident we'll be able to fully meet the opportunities and challenges of today and tomorrow."    <P>
In addition to the appointment of Mr. Snow as COO, Amedisys is also adding a new role to its current leadership team.  The Chief Development Officer (CDO) role is being added to drive growth strategies, including new products and emerging business lines that support the company's long term Comprehensive, Continuous Chronic Care Management (C4M) strategy.      <P>
In his role as CDO of Amedisys, Mr. Barfield will be responsible for the Company's growth strategies including implementation of the Company's acquisition and start up strategy as well as new products and emerging business lines. Throughout his career, Mr. Barfield has proven himself to be a high capacity, engaging leader with an outstanding ability to elicit the best in thinking from his staff.  Given Amedisys' goal of becoming the undisputed national leader in multidisciplinary chronic care management, the organization is seeking to leverage his relationship skills and his capacity to identify and foster creative thinking to orchestrate the transformation from a homecare to a post acute chronic care company.      <P>
Most recently, Mr. Barfield served as the Executive Counsel to Louisiana Governor Bobby Jindal, where he provided legal representation to the Governor and his staff, as well as serving as an advisor on key policy, strategic, operational and transactional matters.  Prior to that appointment, Mr. Barfield served as the Executive Director of the Louisiana Workforce Commission for the Jindal administration.  Appointed by the Governor to lead reform of the state's workforce development system, Mr. Barfield led the development and implementation of the Governor's workforce policy and legislative agenda.  Mr. Barfield's compelling leadership led to innovative policy and legislative changes all of which represented significant contributions to the state of Louisiana.         <P>
Prior to his tenure in public service,  Mr. Barfield was employed by The Shaw Group, a Fortune 500 engineering, technology, construction, fabrication, environmental and industrial services company with approximately 22,000 employees and 180 locations throughout the world.  During his twelve years at The Shaw Group, Mr. Barfield served as the President and Chief Operating Officer in addition to other senior management positions. Additionally, he is a licensed attorney and previously worked for the law firm Vinson & Elkins, LLP, where he specialized in mergers and acquisitions.  Mr. Barfield will begin his duties as CDO on January 11, 2010.    <P>
"I am very excited to be joining such a growing and dynamic company." said Tim Barfield, Chief Development Officer of Amedisys, Inc.  "Amedisys is well positioned to play a key role in the future of healthcare. I am looking forward to assisting in the Company's mission of delivering high quality, cost effective post acute care services."     <P>
Amedisys, Inc. is headquartered in Baton Rouge, Louisiana.  Its common stock trades on the NASDAQ Global Select Market under the symbol "AMED."    <P>
<em>This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect", "anticipate" or similar expressions.  Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements.  Many of the factors that could cause or contribute to such differences are described in the Company's periodic reports and registrations statements filed with the Securities and Exchange Commission, and include, but are not limited to the following: general economic and business conditions, changes in or failure to comply with existing regulations or the inability to comply with new government regulations on a timely basis, changes in Medicare and other medical reimbursement levels, ability to complete acquisitions announced from time to time, and any financing related thereto, the ability to meet debt service requirements and to comply with covenants in debt agreements, adverse changes in federal and state laws relating to the health care industry, demographic changes, availability and terms of capital, ability to attract and retain qualified personnel, ongoing development and success of new start-ups, ability to successfully integrate newly acquired agencies, changes in estimates and judgments associated with critical accounting policies, business disruption due to natural disasters or acts of terrorism, and various other matters, many of which are beyond management's control. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.</em>     <P>
<em>Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page.  We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information.  In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").</em>    <P>
<a href="http://www.amedisys.com">www.amedisys.com</a> <P>]]></description>
      <pubDate>2010-01-05 00:00:00.0</pubDate> 
      <link>http://www.amedisys.com/press_release.cfm?ID=212</link> 
      <creator>Amedisys.com</creator> 
    </item> 
		

	
         

  </channel> 
</rss>
